A benchmark for antibodies: Open dataset aims to standardize sequencing and measurement

Antibodies are the immune system's precision tools for recognizing and neutralizing viruses, bacteria and other foreign ...
Healio

Investigational drug that reduces hepcidin offers promise for treating anemia

Please provide your email address to receive an email when new articles are posted on . Researchers report positive results from a phase 1b/2a placebo-controlled study of DISC-0974, an ...

Ouro Medicines Receives U.S. FDA Fast Track Designation for Gamgertamig in Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

Ouro Medicines, a clinical stage biotechnology company developing immune reset therapeutics for people living with chronic, ...
Science Daily

Stanford makes stem cell transplants safer without chemo

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, ...
KTLA

Ouro Medicines Announces Initiation of OM336 Basket Study in Autoimmune Cytopenias and Granting of U.S. FDA Orphan Drug Designation for OM336 in Autoimmune Hemolytic Anemia (AIHA)

SAN FRANCISCO, Aug. 5, 2025 /PRNewswire/ -- Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated diseases, today announced the ...
Monthly Prescribing Reference

Ziltivekimab Improves Anemia Parameters in Patients With CKD

Ziltivekimab, an anti-IL-6 ligand antibody, increases iron and other anemia parameters in patients with chronic kidney disease. Ziltivekimab, a novel anti-IL-6 ligand antibody, improves ...